Table 5 |
||||||||
|
Discontinuation of anti-diabetic treatment |
||||||||
|
Females |
Males |
|||||||
|
|
|
|||||||
|
One year gap |
Two years gap |
One year gap |
Two years gap |
|||||
|
Year |
n |
% |
n |
% |
n |
% |
n |
% |
|
|
||||||||
|
1993 |
198 |
6.6 |
174 |
5.6 |
||||
|
1994 |
209 |
6.7 |
118 |
3.5 |
185 |
5.7 |
99 |
2.8 |
|
1995 |
199 |
6.2 |
133 |
3.8 |
188 |
5.5 |
115 |
3.1 |
|
1996 |
172 |
5.3 |
121 |
3.5 |
203 |
5.8 |
108 |
2.9 |
|
1997 |
188 |
5.5 |
101 |
2.8 |
196 |
5.2 |
113 |
2.8 |
|
1998 |
163 |
4.6 |
123 |
3.3 |
182 |
4.6 |
117 |
2.8 |
|
1999 |
135 |
3.7 |
102 |
2.7 |
166 |
4.0 |
108 |
2.5 |
|
2000 |
150 |
4.0 |
92 |
2.3 |
194 |
4.5 |
97 |
2.1 |
|
2001 |
282 |
7.1 |
100 |
2.4 |
375 |
8.2 |
114 |
2.3 |
|
2002 |
176 |
4.2 |
117 |
2.6 |
233 |
4.8 |
122 |
2.4 |
|
2003 |
189 |
4.2 |
99 |
2.1 |
250 |
4.9 |
126 |
2.3 |
|
|
||||||||
|
Number of patients discontinuing anti-diabetic treatment, Fyn County, Denmark, 1994–2003. Discontinuation is defined as subjects with more than one or two years, respectively, without redemptions after a previous redemption. Percentage figures indicate relative proportion of the prevalent population who discontinues treatment. |
||||||||
|
Støvring et al. Population Health Metrics 2007 5:2 doi:10.1186/1478-7954-5-2 |
||||||||